Category : MiscellaneousPublished on: September 09 2024
Share on facebook
Alembic Pharmaceuticals has received approval from the US health regulator to market a generic drug used to treat moderate to severe psoriasis of the scalp.
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for betamethasone valerate foam.